Literature DB >> 9035176

Hemodialysis catheter survival and complications in children and adolescents.

S L Goldstein1, C T Macierowski, K Jabs.   

Abstract

Venous catheters have become an indispensable form of hemodialysis access. We evaluated catheter performance as temporary and long-term access in children with end-stage renal disease (ESRD). We assessed the survival rates and causes of catheter failure in 78 catheters used for hemodialysis access in 23 pediatric patients (aged 10 months to 22 years) with ESRD over a 5-year period. Median survival was 31 days for 56 uncuffed catheters. One- and 2-month actuarial survival was 69% and 48%, respectively. Reasons for removal were: elective (39%), kinking (36%), trauma (11%), infection (7%), and other (5%). Smaller catheters (7 or 9 French) were more likely to be removed for kinking (P = 0.003). One-year actuarial survival for 22 cuffed catheters was 27%. Cuffed catheters were removed due to: infection (36%), kinking (14%), elective (9%), trauma (9%) and other (9%). Twelve catheters were removed for infection. Infection rates leading to removal were 0.58 and 0.71 per patient-year for uncuffed and cuffed catheters, respectively. Staphylococcus species were cultured most commonly. We conclude that uncuffed catheters function well for short-term hemodialysis access of up to 2 months' duration and cuffed catheters are successful for long-term access in children and adolescents with ESRD.

Entities:  

Mesh:

Year:  1997        PMID: 9035176     DOI: 10.1007/s004670050235

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

Review 1.  Hemodialysis in children: general practical guidelines.

Authors:  M Fischbach; A Edefonti; C Schröder; A Watson
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

2.  Patterns of use of vascular catheters for hemodialysis in children in the United States.

Authors:  Jeffrey J Fadrowski; Wenke Hwang; Alicia M Neu; Barbara A Fivush; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

3.  Systemic anticoagulation and bleeding in children with hemodialysis catheters.

Authors:  Michael L Moritz; Abhay Vats; Demetrius Ellis
Journal:  Pediatr Nephrol       Date:  2002-11-21       Impact factor: 3.714

4.  Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Sheila Coakley; Carolyn Abitbol; Brenda Montane; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

5.  Low infection rates and prolonged survival times of hemodialysis catheters in infants and children.

Authors:  Israel Eisenstein; Mahdi Tarabeih; Daniella Magen; Shirley Pollack; Imad Kassis; Amos Ofer; Ahuva Engel; Israel Zelikovic
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-02       Impact factor: 8.237

6.  Neurologic and ophthalmologic complications of vascular access in a hemodialysis patient.

Authors:  Roxana Cleper; Nitza Goldenberg-Cohen; Liora Kornreich; Irit Krause; Miriam Davidovits
Journal:  Pediatr Nephrol       Date:  2007-05-09       Impact factor: 3.714

7.  Central venous lines for chronic hemodialysis: survey of the Midwest Pediatric Nephrology Consortium.

Authors:  Rudolph P Valentini; Denis F Geary; Deepa H Chand
Journal:  Pediatr Nephrol       Date:  2007-11-16       Impact factor: 3.714

Review 8.  Catheter-related infections in children treated with hemodialysis.

Authors:  Fabio Paglialonga; Susanna Esposito; Alberto Edefonti; Nicola Principi
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

9.  Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Nancy Simon; Marie Saint-Vil; Denise Francoeur; Obioma Nwobi; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2007-12-06       Impact factor: 3.714

Review 10.  Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners.

Authors:  Deepa H Chand; Rudolph P Valentini; Elaine S Kamil
Journal:  Pediatr Nephrol       Date:  2008-04-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.